References
- Biti G P, Cimino G, Cartoni S M. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: Eight-year update of an Italian prospective randomized study. J Clin Oncol 1992; 10: 378–382
- Boivin J-F, Hutchison G B, Lubin J H, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 1992; 69: 1241–1247
- Canellos G P, Anderson J R, Propert K J. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD. N Engl J Med 1992; 327: 1478–1484
- Chopra R, Goldstone A H, Pearce R. Autol-ogous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: A case-controlled analysis of the European Bone Marrow Transplant Group registry data. J Clin Oncol 1992; 10: 1690–1695
- DeAngelis L M, Yahalom J, Thaler H T, Kher U. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992; 10: 635–643
- Grossbard M L, Freedman A S, Ritz J. Serotherapy of B-cell neoplasms with anti B4-blocked ricin: A phase I trial of daily bolus infusion. Blood 1992; 79: 1576–485
- Herbst H, Steinbrecher E, Niedobitek G. Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease. Blood 1992; 80: 484–491
- Hessol N A, Katz M H, Liu J Y. Increased incidence of Hodgkin's disease in homosexual men with HIV infection. Ann Intern Med 1992; 117: 309–311
- Hochster H S, Kim K, Green M D. Activity of fludarabine in previously treated non-Hodgkin lymphoma: Results of an Eastern Cooperative Oncology Group study. J Clin Oncol 1992; 10: 28–32
- Kwak L W, Campbell M J, Dzerwinski D K. Induction of immune responses in patients with B-cell lymphoma against the surface-immuno-globulin idiotype expressed by their tumors. N Engl J Med 1992; 327: 1209–1215
- Longo D L, Duffey P L, Young R C. Conventional-dose salvage combination chemo-therapy in patients relapsing with Hodgkin's disease after combination chemotherapy. The low probability for cure. J Clin Oncol 1992; 10: 210–218
- Redman J, Cabanillas R. F, Velasquez W S. Phase II-trial of fludarabine phosphate in lym-phoma: An effective new agent in low grade lym-phoma. J Clin Oncol 1992; 10: 790–794
- Saven A, Carrera C J, Carson D A. 2-chloro-deoxyadenosine: An active agent in the treatment of cutaneous T-cell lymphoma. Blood 1992; 80: 587–592
- Shiramizu B, Herndier B, Meeker T. Molecular and imniunophenotypic characterization of AIDS-Associated Epstein-Barr virus negative. poly-clonal lymphoma. J Clin Oncol 1992; 10: 383–389
- Smalley R V, Anderson J W, Hawkins M J. In-terferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma. N Engl J Med 1992; 327: 1336–1341
- Straus D J, Yahalom J, Gaynor J. Four cycles of chemotherapy and regional radiation therapy for clinical early-stage and intermediate-stage Hodgkin's disease. Cancer 1992; 10(69)50–1060